| Literature DB >> 35565897 |
Anja Lazić1, Miodrag Kocić1, Nebojša Trajković1, Cristian Popa2, Leonardo Alexandre Peyré-Tartaruga3, Johnny Padulo4.
Abstract
Caffeine supplementation has become increasingly popular among athletes. The benefits of caffeine include delaying the negative effects of fatigue, maintaining a high level of physical and mental performance, and improving certain abilities necessary for sport success. Given the complex nature of basketball, caffeine could be a legal, ergogenic stimulant substance, which will positively affect overall basketball performance. The purpose of this systematic review was to summarize evidence for the effect of acute caffeine ingestion on variables related to the basketball performance. Web of Science, PubMed, Scopus and ProQuest, MEDLINE, and ERIC databases were searched up to February 2021. Studies that measured the acute effect of caffeine on basketball performance were included and analyzed. Eight studies published between 2000 and 2021 were included in the analysis. Pre-exercise caffeine intake increased vertical jump height, running time at 10 and 20 m without the ball, overall basketball performance (number of body impacts, number of free throws, rebounds, and assists) during simulated games, and reduced the time required to perform a basketball-specific agility test. Equivocal results between caffeine and placebo groups were found for aerobic capacity, free throw and three-point accuracy, and dribbling speed. Pre-exercise caffeine ingestion did not affect RPE, but insomnia and urinary excretion were increased. The pre-exercise ingestion of 3 and 6 mg/kg caffeine was found to be effective in increasing several physical performance variables in basketball players during sport-specific testing and simulated matches. However, considering the intermittent nature and complexity of basketball, and individual differences between players, future studies are needed.Entities:
Keywords: agility; explosive power; nutrition; speed; supplementation; team sport
Mesh:
Substances:
Year: 2022 PMID: 35565897 PMCID: PMC9099691 DOI: 10.3390/nu14091930
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 6.706
Figure 1PRISMA preferred reporting items for systematic reviews and meta-analysis.
Descriptive statistics of the participants and PEDro scale for assessing quality of included studies.
| Study | Participants | Level of Playing | Daily Caffeine Intake (mg/day, week) | PEDro Score | ||
|---|---|---|---|---|---|---|
| M/F | N | Age (Years) | ||||
| Tucker et al. [ | M | 5 | 22 ± 1 | professional | <500 | 8 |
| Abian-Vicen et al. [ | M | 16 | 14.9 ± 0.8 | professional | <60 | 9 |
| Puente et al. [ | M/F | 10/10 | 27.1 ± 4.0/27.9 ± 6.1 | professional | <100 | 9 |
| Puente et al. [ | M/F | 10/9 | 26.5 ± 2.4/27.0 ± 5.3 | professional | <100 | 10 |
| Scanlan et al. [ | M/F | 11/10 | 18.3 ± 3.3 | professional | <100 | 10 |
| Stojanović et al. [ | F | 10 | 20.2 ± 3.9 | professional | <100 | 10 |
| Tan et al. [ | M/F | 12/6 | 23.1 ± 1.9/22.0 ± 1.3 | college | <200 | 10 |
| Stojanović et al. [ | M | 11 | 16.5 ± 1.0 | juniors | 310 ± 76 | 10 |
M/F—male/female; N—number; AA—AA homozygotes; CC—allele carriers, PEDro—Physiotherapy Evidence Database Scale.
Experimental program of acute caffeine ingestion in basketball players.
| Study | Form | Dose (mg/kg) | Timing | Variables (Unit) | Placebo | Caffeine | Results |
|---|---|---|---|---|---|---|---|
| Tucker et al. [ | Capsule | 3 | 60 | VO2max (rep) | 118/126/109/122/83 ± 13/14/6/14/4 | 124/117/119/111/87 ± 5/13/9/9/4 | ↔ |
| Abian-Vicen et al. [ | Energy drink | 3 | 60 | FTA (%) | 70.7 ± 11.8 | 70.3 ± 11.0 | ↔ |
| Puente et al. [ | Capsule | 3 | 60 | VJ (cm) | 37.3 ± 6.8 | 38.2 ± 7.4 | ↑ |
| Puente et al. [ | Capsule | 3 | 60 | VJ (cm) | 39.6 ± 7.2/36.3 ± 5.9 | 40.7 ± 7.3/37.2 ± 6.9 | ↑/↔ |
| Scanlan et al. [ | Capsule | 3 | 60 | TDT20m (s) | 3.560 ± 0.184 | 3.528 ± 0.208 | ↔ |
| Stojanović et al. [ | Capsule | 3 | 60 | CMJ (cm) | 27.92 ± 4.24 | 29.20 ± 4.39 | ↑ |
| Tan et al. [ | Capsule | 6 | 60 | FTA (%) | 5.5 ± 2.0 | 6.1 ± 1.7 | ↔ |
| Stojanović et al. [ | Capsule | 3 | 60 | CMJ am/pm (cm) | 31.03 ± 4.98 (am) | 33.90 ± 5.38 (am) | ↑ |
VO2max—maximal oxygen uptake; VJ—vertical jumps; FTA—free throw accuracy; TPA—three point accuracy; CMJ—countermovement jump; RJ—repeated jumps; YoYo IR 1—yoyo intermittent recovery test; UE—urinary excretion; CODAT (wb)—change of direction agility test (with ball); Reb—rebounds; Ass—assists; Imp—body impacts; PIR—performance index; POI—prevalence of insomnia; Mhr—mean heart rate; Phr—peak heart rate; TDT—total dribbling time; DD—dribbling deficit; CMJa—countermovement jump with arm swing; SJ—squat jump; LAT—lane agility drill test; RSA (wb)—repeated sprint ability (with ball); RPE—perceived exertion; PP—performance; HR—heart rate; am—morning; pm—evening; amc—morning caffeine group; pmc—evening caffeine group; ↑—improvement; ↓—reduction; ↔—unchanged.